Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir

Postgraduate Medical Journal

Volumn 75, Issue 887, 1999, Pages 546-547

  Blanche, P ^a   Rigolet, A ^a   Gombert, B ^a   Ginsburg, C ^a   Salmon, D ^a   Sicard, D ^a  

^a Univ René Descartes ^*  (France)

Author keywords

Adverse drug reaction; AIDS; Ergotamine tartrate; Ergotism; HIV infection; Ritonavir

Indexed keywords

ERGOTAMINE TARTRATE; ILOPROST; PROSTACYCLIN DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERGOTISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE;

EID: 0032837924     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.75.887.546     Document Type: Article

References (5)

1. Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992;23:106-31.
2. Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995;333:1528-
3. Lea AP, Faulds D. Ritonavir. Drugs 1996;52:541-6.
4. Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, Del Nozal M, Lopez-Cortes LF. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient. Antimicrob Ag Chemother 1997;41:1207.
5. Moyle G, Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 1996;51:701-12.